Type 2 diabetes. Type 2 diabetes mellitus
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Informed consent; Age between 18 and 70 years; Definitive diagnosis of type 2 diabetes based on physician diagnosis; Hemoglobin A1C less than 8.5; At least 6 months have passed since diagnosis of type 2 diabetes;Participants who were using oral hypoglycemic drugs, insulin, or diet control at the time of the study and their treatment regimen had been stable for at least 3 months.
Exclusion criteria
Exclusion criteria: Patients at high risk for hypoglycemia Immunodeficiency Pregnancy and lactation Uncontrolled blood pressure Liver and kidney failure Uncontrolled thyroid disease Concomitant use of any drug that inhibits or induces moderate to strong hepatic isoenzymes and P-glycoprotein History of use of antipsychotics, psychotropic drugs, or alcohol and anticoagulant drugs Concomitant use of two antiplatelet drugs Patients with a diagnosis of neurological diseases or psychiatric disorders
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fasting blood sugar. Timepoint: Beginning of the study, end of the sixth and twelfth weeks. Method of measurement: Blood test.;HbA1C. Timepoint: Beginning of the study, end of the sixth and twelfth weeks. Method of measurement: Blood test.;Blood sugar after a meal. Timepoint: Beginning of the study, end of the sixth and twelfth weeks. Method of measurement: Blood test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Kermanshah University of Medical Sciences